Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Three-way Crossover Comparative Water-effect Bioavailability to Compare Ondansetron ODFS 8mg With and Without Water With Zofran ODT 8mg Without Water in 18 Healthy Participants Under Fasting Conditions

This study has been completed.
Information provided by:
Par Pharmaceutical, Inc. Identifier:
First received: October 12, 2010
Last updated: July 25, 2011
Last verified: October 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2008
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)